Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) StudyT C, David Oscier, David Donaldson et al.|Blood|2024Cited by 0
The Role of Adenosine Deaminase Acting on RNA 1 (ADAR1) Enzyme in the Resistance to Hypomethylating AgentsDespoina Dimitriou, Ιoannis Kotsianidis, Eleftheria Lamprianidou et al.|Blood|2024Cited by 0
The Role of the Adenosinergic Pathway in the Resistance to Hypomethylating AgentsGeorge Vrachiolias, Ιoannis Kotsianidis, Eleftheria Lamprianidou et al.|Blood|2024Cited by 0
PROGNOSIS - PREDICTIVE FACTORS OF RESPONSE TO TREATMENTGeorge Vrachiolias, Ιoannis Kotsianidis, Eleftheria Lamprianidou et al.|Leukemia Research|2025Cited by 0
PLENARY SESSION 08: TREATMENT HIGH RISKDespoina Dimitriou, Ιoannis Kotsianidis, Panagiotis Liakopoulos et al.|Leukemia Research|2025Cited by 0